Doctor profile · Federal record
Dr. MANISH JAIN, M.D.
Rheumatology Physician (CMS: RHEUMATOLOGY) · Student in an Organized Health Care Education/Training Program · Student in an Organized Health Care Education/Training Program · CHICAGO, IL
- NPI 1417075581
- Accepts Medicare
- MIPS 90.0 / 100 · 2023
- 15 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
1945 W WILSON AVE STE 100
CHICAGO, IL 606407927
(773) 769-9040 - Additional location
-
2845 N Sheridan Rd, Suite 6400
Chicago, IL 60657
(773) 665-8400 - Additional location
-
800 Austin St, Suite 208
Evanston, IL 602023439
(847) 866-8988
fax (847) 866-8990 - Mailing address
-
800 AUSTIN ST, SUITE 208
EVANSTON, IL 602023439
Credentials & registration
- NPI registered
- March 2007 — 19 yrs on file
- Profile last updated
- May 30, 2023
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (3)
- Illinois #036130313 · New York #253170-1 · Michigan #4301088345
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1417075581. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
18,378
Distinct HCPCS
10
Medicare allowed
$385,763
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 14,352 | 23 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 2,760 | 28 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 542 | 238 | $133 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 195 | 37 | $133 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 146 | 11 | $76 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 108 | 16 | $1 | |
96372 |
Injection of drug or substance under skin or into muscle | 87 | 30 | $15 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 75 | 49 | $94 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 54 | 54 | $175 | |
20610 |
Aspiration and/or injection of fluid from large joint | 37 | 20 | $70 |
In context: peer comparison
Among 36 peers in this city , average services per provider: 1,230. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$206,089
Transactions
258
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 80 | $120,982.73 | |
| Amgen Inc. | 53 | $44,866.77 | |
| Janssen Biotech, Inc. | 31 | $24,272.34 | |
| GlaxoSmithKline, LLC. | 15 | $9,000.14 | |
| Lilly USA, LLC | 11 | $3,268.26 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $1,727.75 | |
| UCB, Inc. | 13 | $1,119.29 | |
| Novartis Pharmaceuticals Corporation | 31 | $350.29 | |
| AstraZeneca Pharmaceuticals LP | 5 | $114.73 | |
| Sandoz Inc. | 5 | $102.18 | |
| Alexion Pharmaceuticals, Inc. | 3 | $70.23 | |
| Genentech USA, Inc. | 2 | $41.66 | |
| Actelion Pharmaceuticals US, Inc. | 1 | $29.07 | |
| Aurinia Pharma U.S., Inc. | 1 | $27.19 | |
| Kiniksa Pharmaceuticals International, plc | 1 | $27.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,552
Patients
414
Total drug cost
$1,035,464
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 310 | 95 | $3,709 |
| Hydroxychloroquine Sulfate | Generic | 300 | 95 | $18,293 |
| Methotrexate (Methotrexate Sodium) | Brand | 257 | 76 | $11,491 |
| Leflunomide | Generic | 133 | 39 | $14,338 |
| Rinvoq (Upadacitinib) | Brand | 89 | 0 | $688,489 |
| Allopurinol | Generic | 77 | 29 | $1,291 |
| Methylprednisolone | Generic | 72 | 25 | $2,021 |
| Alendronate Sodium | Generic | 57 | 13 | $710 |
| Gabapentin | Generic | 54 | 19 | $531 |
| Enbrel Sureclick (Etanercept) | Brand | 40 | 0 | $289,810 |